?????????????.??????????????????????????????????????102 Conversely, quite a few groups are advocating for that incorporation of novel markers, like a complicated karyotype55 or epigenetic subsets, 27,28 into clinical practice. Every one of these novel prognostic and/or predictive styles will need to be validated in cohorts of patients dealt with wi